Filtered By:
Condition: Headache
Countries: USA Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 40 results found since Jan 2013.

Extreme Heat Is Endangering America ’ s Workers —And Its Economy
This project was supported by the Pulitzer Center 7 A.M.: COPELAND FARMS—ROCHELLE, GA Just after dawn on a recent July day in Rochelle, Ga., Silvia Moreno Ayala steps into a pair of sturdy work pants, slips on a long-sleeved shirt, and slathers her face and hands with sunscreen. She drapes a flowered scarf over her wide-brimmed hat to protect her neck and back from the punishing rays of the sun. There isn’t much she can do about the humidity, however. Morning is supposed to be the coolest part of the day, but sweat is already pooling in her rubber boots. [time-brightcove not-tgx=”true”] ...
Source: TIME: Health - August 3, 2023 Category: Consumer Health News Authors: Aryn Baker / Georgia Tags: Uncategorized climate change Climate Is Everything feature healthscienceclimate Source Type: news

Will unpredictable side effects dim the promise of new Alzheimer ’s drugs?
A sea change is underway in the treatment of Alzheimer’s disease, where for the first time a drug that targets the disease’s pathology and clearly slows cognitive decline has hit the U.S. market. A related therapy will likely be approved in the coming months. As many neurologists, patients, and brain scientists celebrate, they’re also nervously eyeing complications from treatment: brain swelling and bleeding, which in clinical trials affected up to about one-third of patients and ranged from asymptomatic to fatal. The side effect—amyloid-related imaging abnormalities, or ARIA—remains mysterious. “We don’...
Source: Science of Aging Knowledge Environment - August 2, 2023 Category: Geriatrics Source Type: research

How to Keep Your Home Cool in Extreme Heat
Global temperatures have reached alarmingly high levels across the U.S., Europe, and Asia as heat waves set record highs this week. Parts of European countries including most of Italy, eastern Croatia, southern Spain, southern Bosnia and Herzegovina, and Montenegro are under red alert, the European Union’s Emergency Response Coordination Centre said on Wednesday. Meanwhile, as of July 18, Phoenix had experienced 19 consecutive days of 110°F temperatures or higher. And Beijing is also experiencing a record stretch of 95°F heat. The extreme heat comes as weather phenomenon El Niño, which occurs every tw...
Source: TIME: Health - July 19, 2023 Category: Consumer Health News Authors: Solcyre Burga Tags: Uncategorized climate change extreme weather healthscienceclimate Source Type: news

Lifelong cerebrovascular disease burden among CADASIL patients: analysis from a global health research network
DiscussionEarly screening and targeted treatment strategies are warranted to help CADASIL patients with symptom management and risk mitigation.
Source: Frontiers in Neurology - July 14, 2023 Category: Neurology Source Type: research

---
Neurologic emergencies can be difficult to diagnose and treat, and are devastating if missed. Stroke is still the number five cause of death in the United States, down from number three a few years ago, and is the leading cause of long-term serious disability. Nonconvulsive status epilepticus is a substantial problem in intensive care units. Traumatic brain injuries from head trauma are a leading cause of post-traumatic stress in many populations. Then we have spine injuries, headache, back pain, infections, and vision problems, which present to emergency departments on a daily basis.
Source: The Journal of Emergency Medicine - April 5, 2023 Category: Emergency Medicine Authors: Edward J. Otten Tags: Book and Other Media Reviews Source Type: research

Pediatric Moyamoya Syndrome Secondary to Tuberculous Meningitis: A Case Report
We report the case of a female patient who initially presented at 6 years of age with TBM and developed moyamoya syndrome requiring revascularization surgery. Results She was found to have basilar meningeal enhancement and right basal ganglia infarcts. She was treated with 12 months of antituberculosis therapy and 12 months of enoxaparin and maintained on daily aspirin indefinitely. However, she developed recurrent headaches and transient ischemic attacks and was found to have progressive bilateral moyamoya arteriopathy. At age 11 years, she underwent bilateral pial synangiosis for the treatment of her moyamoya syndrome. ...
Source: Neurology Clinical Practice - January 18, 2023 Category: Neurology Authors: Kappel, A. D., Lehman, L. L., Northam, W. T., See, A. P., Smith, E. R. Tags: Clinical/Scientific Note Source Type: research

E-060 Analysis of reported adverse events of flow-diverter stents for intracranial aneurysms using the FDA MAUDE database
ConclusionsPost-market surveillance is an important to guide patient counselling and identify adverse events and device problems that were not identified in initial trials. Although there are inherent limitations to the MAUDE database, our results highlight some important PR and DR complications that can help optimize patient counseling and management.Disclosures M. Porwal: None. G. SenthilKumar: None. D. Kumar: None. G. Sinson: None.
Source: Journal of NeuroInterventional Surgery - July 23, 2022 Category: Neurosurgery Authors: Porwal, M., SenthilKumar, G., Kumar, D., Sinson, G. Tags: SNIS 19th annual meeting electronic poster abstracts Source Type: research

Acute Stroke Diagnosis
Am Fam Physician. 2022 Jun 1;105(6):616-624.ABSTRACTStroke accounts for significant morbidity and mortality and is the fifth leading cause of death in the United States, with direct and indirect costs of more than $100 billion annually. Expedient recognition of acute neurologic deficits with appropriate history, physical examination, and glucose testing will help diagnose stroke and rule out mimicking presentations. The National Institutes of Health Stroke Scale should be used to determine stroke severity and to monitor for evolving changes in clinical presentation. Initial neuroimaging is used to differentiate between isc...
Source: American Family Physician - June 15, 2022 Category: Primary Care Authors: Edwin Y Choi Gilberto A Nieves Darrell Edward Jones Source Type: research

What Extreme Heat Does to the Human Body
For the third weekend in a row, large swaths of the United States have wilted under early-season heatwaves that have set high temperature records from California to Texas. Nearly 100 million Americans are facing heat warnings and advisories from the southwest to the Mississippi River, with temperatures spiking well into the triple digits in California, Texas, Arizona, and Colorado. As much of the northern hemisphere heads into what is projected to be a hotter-than-usual summer, more people will be exposed to dangerous levels of high heat and humidity. Heatwaves kill more people annually in the U.S. than hurricanes, lightni...
Source: TIME: Health - June 13, 2022 Category: Consumer Health News Authors: Aryn Baker Tags: Uncategorized climate change Climate Is Everything Explainer extreme weather healthscienceclimate Londontime overnight Source Type: news

Pregnancy-Related Stroke: A Review
Conclusions and Relevance Early recognition and management are integral in decreasing the morbidity and mortality associated with a stroke in pregnancy. Relevance Statement This study was an evidence-based review of stroke in pregnancy and how to diagnose and mange a pregnancy complicated by a stroke. Target Audience Obstetricians and gynecologist, family physicians Learning Objectives After completing this learning activity, the participant should be better able to identify the pregnancy-related risk factors for a stroke; explain the presenting signs and symptoms of a stroke in pregnancy; describe...
Source: Obstetrical and Gynecological Survey - June 1, 2022 Category: OBGYN Tags: CME ARTICLES Source Type: research

New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition (DPI) with XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD)
RARITAN, N.J., May 23, 2022 – Findings from the XARELTO® (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and the XARELTO® in Combination with Acetylsalicylic Acid (XATOA) registry have been published in the European Society of Cardiology’s (ESC) European Heart Journal, Cardiovascular Pharmacotherapy. Additionally, the XATOA registry was presented at the American Congress of Cardiology’s 71st Annual Scientific Session (ACC.22). These studies provide further evidence supporting the role of dual pathway inhibition (DPI) with the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 100 mg...
Source: Johnson and Johnson - May 23, 2022 Category: Pharmaceuticals Source Type: news

Health and cognition among adults with and without Traumatic Brain Injury: A matched case-control study
CONCLUSION: Individuals with TBI have greater odds of selected neurobehavioral conditions compared to their demographically similar uninjured peers. Among persons with TBI there was a stronger association between poorer self-rated health and cognition than controls. TBI is increasingly conceptualized as a chronic disease; current findings suggest post-TBI health management requires cognitive supports.PMID:35143349 | DOI:10.1080/02699052.2022.2034190
Source: Brain Injury - February 10, 2022 Category: Neurology Authors: Raj G Kumar Jessica M Ketchum Flora M Hammond Thomas A Novack Therese M O'Neil-Pirozzi Marc A Silva Kristen Dams-O'Connor Source Type: research

New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news